+44.1%
GSK vs ESTC
-48.9%
+93.0%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ESTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +2.2% | -2.4% | -0.2% |
| 7D | +1.7% | -11.5% | +13.2% | +1.9% |
| 30D | +7.0% | -7.5% | +14.6% | +7.1% |
| 3M | -2.7% | +23.1% | -25.7% | -3.1% |
| 6M | +1.4% | +75.3% | -73.9% | +0.2% |
| YTD | +5.3% | +14.1% | -8.8% | +5.1% |
| 1Y | +10.6% | -0.6% | +11.2% | +10.8% |
| 3Y | +62.6% | +20.8% | +41.8% | +59.0% |
| All | +44.1% | -48.9% | +93.0% | +40.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ESTC.
Daily Out/Under-Performance
Portfolio return minus ESTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ESTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ESTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling